⌘K
Loading ticker…
Fidelity Disruptive Medicine ETF · Other
3m RS is unavailable, Market Stance is 47.8
As of 2026-08-24, Fidelity Disruptive Medicine ETF (FMED) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Other. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
| # | Holding | Weight | Value |
|---|---|---|---|
| 1 | UCB SA | 4.73% | $2M |
| 2 | LFST | 4.27% | $2M |
| 3 | DHR | 3.42% | $1M |
| 4 | TXG | 3.11% | $1M |
| 5 | ISRG | 2.92% | $1M |
| 6 | COGT | 2.85% | $1M |
| 7 | ALNY | 2.79% | $1M |
| 8 | ARGX | 2.78% | $1M |
| 9 | LEGN | 2.29% | $940K |
| 10 | UNH | 2.25% | $922K |
| 11 | TECH | 2.24% | $919K |
| 12 | EDWARDS LIFESCIENCES CORP | 2.11% | $865K |
| 13 | MRNA | 2.11% | $863K |
| 14 | KYMR | 1.99% | $814K |
| 15 | XENE | 1.92% | $786K |
| 16 | HTFL | 1.89% | $774K |
| 17 | INSM | 1.79% | $735K |
| 18 | VEEV | 1.78% | $730K |
| 19 | PCVX | 1.77% | $723K |
| 20 | RVMD | 1.73% | $709K |
| 21 | CAI | 1.71% | $702K |
| 22 | CRNX | 1.65% | $675K |
| 23 | AXSM | 1.57% | $645K |
| 24 | CYTK | 1.55% | $634K |
| 25 | VCYT | 1.54% | $631K |
Showing 25 of 61 holdings.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | FMED Jan avg: 1.65% median: -0.36% win: 33% σ: 4.40% n: 3 2023-06-13 → 2026-07-31 | FMED Feb avg: -0.62% median: -1.74% win: 33% σ: 4.39% n: 3 2023-06-13 → 2026-07-31 | FMED Mar avg: -3.66% median: -6.19% win: 33% σ: 4.45% n: 3 2023-06-13 → 2026-07-31 | FMED Apr avg: -1.36% median: 0.97% win: 67% σ: 4.36% n: 3 2023-06-13 → 2026-07-31 | FMED May avg: -0.77% median: -1.54% win: 33% σ: 1.96% n: 3 2023-06-13 → 2026-07-31 | FMED Jun avg: 4.33% median: 2.34% win: 75% σ: 6.18% n: 4 2023-06-13 → 2026-07-31 | FMED Jul avg: 0.17% median: -0.05% win: 50% σ: 2.07% n: 4 2023-06-13 → 2026-07-31 | FMED Aug avg: 0.99% median: 3.53% win: 67% σ: 6.04% n: 3 2023-06-13 → 2026-07-31 (current) | FMED Sep avg: -1.48% median: 1.04% win: 67% σ: 5.04% n: 3 2023-06-13 → 2026-07-31 | FMED Oct avg: -2.07% median: -2.89% win: 33% σ: 6.79% n: 3 2023-06-13 → 2026-07-31 | FMED Nov avg: 6.30% median: 6.12% win: 100% σ: 3.60% n: 3 2023-06-13 → 2026-07-31 | FMED Dec avg: 0.13% median: -6.02% win: 33% σ: 10.79% n: 3 2023-06-13 → 2026-07-31 |
Metrics matched 56 tickers across 61 holdings rows (80.9% of fund weight). Metrics as of 2026-08-24; holdings from the filing.
Position changes from the to the N-PORT filing.
| Holding | Before → after | Δ weight |
|---|---|---|
| HTFLHEARTFLOW INC | — → 1.89% | — |
| RVMDREVOLUTION MEDICINES INC | — → 1.73% | — |
| AXSMAXSOME THERAPEUTICS INC | — → 1.57% | — |
| BTSGBRIGHTSPRING HEALTH SERVICES INC | — → 1.53% | — |
| VRDNVIRIDIAN THERAPEUTICS INC | — → 1.34% | — |
+4 more
| Holding | Before → after | Δ weight |
|---|---|---|
| LFSTLIFESTANCE HEALTH GROUP INC |
Holdings of FMED currently on TickerStance stock-RS leaderboards.
| 2.46% → 4.27% |
| +1.82 pp |
| TECHBIO TECHNE CORP | 0.81% → 2.24% | +1.43 pp |
| TXG10X GENOMICS INC | 1.70% → 3.11% | +1.41 pp |
| UNHUNITEDHEALTH GROUP INC | 1.43% → 2.25% | +0.82 pp |
| XENEXENON PHARMACEUTICALS INC | 1.11% → 1.92% | +0.81 pp |
+17 more
| Holding | Before → after | Δ weight |
|---|---|---|
| BSXBOSTON SCIENTIFIC CORP | 4.04% → 1.44% | −2.60 pp |
| WAYWAYSTAR HOLDING CORP | 2.53% → 0.98% | −1.54 pp |
| PODDINSULET CORP | 2.58% → 1.10% | −1.48 pp |
| VEEVVEEVA SYS INC | 2.99% → 1.78% | −1.21 pp |
| ARGXARGENX SE | 3.84% → 2.78% | −1.06 pp |
+21 more
| Holding | Before → after | Δ weight |
|---|---|---|
| PENPENUMBRA INC | 1.70% → — | — |
| ASCENDIS PHARMA A/S | 1.48% → — | — |
| RMDRESMED INC | 1.18% → — | — |
| CENTESSA PHARMACEUTICALS PLC | 1.00% → — | — |
| DOCSDOXIMITY INC | 0.64% → — | — |
+2 more
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| 1.43% |
| 3M RS |
| 187 |
| Stage 2 |